Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fragile X Syndrome | 28 | 2022 | 154 | 8.070 |
Why?
|
| Fragile X Mental Retardation Protein | 25 | 2022 | 128 | 6.130 |
Why?
|
| Down Syndrome | 14 | 2020 | 227 | 2.990 |
Why?
|
| Chromosomes, Human, Pair 21 | 12 | 2019 | 102 | 2.990 |
Why?
|
| Nondisjunction, Genetic | 9 | 2019 | 21 | 2.260 |
Why?
|
| Ataxia | 9 | 2022 | 182 | 2.260 |
Why?
|
| Primary Ovarian Insufficiency | 6 | 2022 | 65 | 2.090 |
Why?
|
| Tremor | 5 | 2022 | 133 | 1.630 |
Why?
|
| Maternal Age | 7 | 2019 | 147 | 1.340 |
Why?
|
| Heterozygote | 6 | 2015 | 1058 | 1.310 |
Why?
|
| Recombination, Genetic | 4 | 2014 | 658 | 1.280 |
Why?
|
| Trinucleotide Repeat Expansion | 6 | 2020 | 141 | 1.280 |
Why?
|
| Meiosis | 6 | 2014 | 175 | 1.220 |
Why?
|
| Atrial Pressure | 1 | 2023 | 6 | 0.860 |
Why?
|
| Dizziness | 1 | 2022 | 42 | 0.800 |
Why?
|
| Menopause, Premature | 1 | 2021 | 16 | 0.760 |
Why?
|
| Patient Positioning | 1 | 2023 | 196 | 0.740 |
Why?
|
| Maternal Exposure | 2 | 2019 | 154 | 0.730 |
Why?
|
| Reproduction | 2 | 2016 | 277 | 0.720 |
Why?
|
| Occupations | 1 | 2019 | 54 | 0.670 |
Why?
|
| Dyspnea | 1 | 2022 | 420 | 0.640 |
Why?
|
| Mutation | 13 | 2022 | 15904 | 0.630 |
Why?
|
| Genetic Carrier Screening | 3 | 2008 | 101 | 0.600 |
Why?
|
| Occupational Exposure | 1 | 2019 | 248 | 0.580 |
Why?
|
| Echocardiography | 1 | 2023 | 1219 | 0.560 |
Why?
|
| Telomere | 1 | 2020 | 546 | 0.550 |
Why?
|
| Pneumonia | 1 | 2023 | 794 | 0.540 |
Why?
|
| Attitude | 2 | 2007 | 162 | 0.500 |
Why?
|
| Exercise | 2 | 2022 | 1209 | 0.480 |
Why?
|
| Trisomy | 2 | 2007 | 240 | 0.480 |
Why?
|
| Hormone Replacement Therapy | 2 | 2016 | 215 | 0.480 |
Why?
|
| Fertility | 1 | 2016 | 335 | 0.450 |
Why?
|
| Anxiety | 2 | 2012 | 1241 | 0.420 |
Why?
|
| Genetic Counseling | 1 | 2015 | 417 | 0.420 |
Why?
|
| RNA-Binding Proteins | 3 | 2004 | 1016 | 0.420 |
Why?
|
| Olfaction Disorders | 1 | 2012 | 31 | 0.410 |
Why?
|
| Alleles | 7 | 2020 | 2597 | 0.410 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2012 | 25 | 0.410 |
Why?
|
| Humans | 56 | 2024 | 271081 | 0.400 |
Why?
|
| Socioeconomic Factors | 2 | 2013 | 1270 | 0.390 |
Why?
|
| DNA Mutational Analysis | 3 | 2015 | 2357 | 0.390 |
Why?
|
| Oocytes | 1 | 2013 | 413 | 0.370 |
Why?
|
| Fathers | 2 | 2009 | 71 | 0.370 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 746 | 0.350 |
Why?
|
| Heart Septal Defects | 3 | 2020 | 48 | 0.350 |
Why?
|
| Trinucleotide Repeats | 5 | 2009 | 137 | 0.340 |
Why?
|
| Heart Failure | 1 | 2023 | 2321 | 0.340 |
Why?
|
| Female | 37 | 2022 | 149115 | 0.330 |
Why?
|
| Neuropsychological Tests | 3 | 2012 | 1143 | 0.320 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2011 | 238 | 0.320 |
Why?
|
| Menopause | 2 | 2008 | 159 | 0.320 |
Why?
|
| Phenotype | 8 | 2020 | 6503 | 0.310 |
Why?
|
| Linear Models | 4 | 2013 | 1095 | 0.310 |
Why?
|
| Students, Medical | 2 | 2024 | 422 | 0.300 |
Why?
|
| Quality Improvement | 1 | 2015 | 913 | 0.300 |
Why?
|
| Quality of Life | 2 | 2022 | 4794 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 3 | 2004 | 1582 | 0.280 |
Why?
|
| Affect | 1 | 2008 | 306 | 0.270 |
Why?
|
| Case-Control Studies | 7 | 2019 | 6240 | 0.270 |
Why?
|
| Homozygote | 1 | 2008 | 772 | 0.270 |
Why?
|
| Adult | 21 | 2020 | 82171 | 0.260 |
Why?
|
| Genetic Testing | 3 | 2015 | 1692 | 0.260 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 986 | 0.260 |
Why?
|
| Male | 28 | 2022 | 128479 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2012 | 4642 | 0.250 |
Why?
|
| Program Development | 1 | 2007 | 259 | 0.250 |
Why?
|
| Teaching | 2 | 2024 | 250 | 0.250 |
Why?
|
| Risk Factors | 9 | 2019 | 17910 | 0.240 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 1557 | 0.240 |
Why?
|
| Genotype | 7 | 2020 | 4249 | 0.240 |
Why?
|
| Chromosome Mapping | 2 | 2004 | 1647 | 0.230 |
Why?
|
| Linkage Disequilibrium | 1 | 2004 | 494 | 0.220 |
Why?
|
| Mitral Valve Prolapse | 1 | 2022 | 30 | 0.210 |
Why?
|
| Qualitative Research | 3 | 2017 | 642 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 5775 | 0.200 |
Why?
|
| Depression | 1 | 2012 | 1735 | 0.200 |
Why?
|
| Headache | 1 | 2023 | 175 | 0.200 |
Why?
|
| Family | 2 | 2019 | 781 | 0.200 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2024 | 199 | 0.200 |
Why?
|
| Gene Frequency | 3 | 2012 | 1247 | 0.190 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 3330 | 0.190 |
Why?
|
| Receptor, Notch4 | 1 | 2020 | 10 | 0.190 |
Why?
|
| Educational Status | 2 | 2013 | 391 | 0.190 |
Why?
|
| Age of Onset | 2 | 2016 | 853 | 0.180 |
Why?
|
| Focus Groups | 2 | 2015 | 286 | 0.180 |
Why?
|
| Mutagenesis | 1 | 2002 | 511 | 0.180 |
Why?
|
| Models, Genetic | 1 | 2004 | 1161 | 0.180 |
Why?
|
| Radiography, Thoracic | 1 | 2023 | 477 | 0.180 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2020 | 15 | 0.170 |
Why?
|
| Clinical Competence | 3 | 2024 | 1332 | 0.170 |
Why?
|
| Telomere Homeostasis | 1 | 2020 | 77 | 0.170 |
Why?
|
| 5' Untranslated Regions | 1 | 2020 | 100 | 0.170 |
Why?
|
| Middle Aged | 13 | 2020 | 90521 | 0.170 |
Why?
|
| Fever | 1 | 2023 | 521 | 0.170 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 573 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2020 | 190 | 0.160 |
Why?
|
| Pregnancy | 4 | 2017 | 8131 | 0.160 |
Why?
|
| Folic Acid | 2 | 2013 | 370 | 0.160 |
Why?
|
| Health Education | 1 | 2021 | 303 | 0.160 |
Why?
|
| Preventive Health Services | 1 | 2019 | 67 | 0.160 |
Why?
|
| Models, Statistical | 1 | 2004 | 1185 | 0.160 |
Why?
|
| Surveys and Questionnaires | 4 | 2013 | 5938 | 0.160 |
Why?
|
| RNA, Messenger | 2 | 2009 | 6343 | 0.150 |
Why?
|
| Genetic Markers | 3 | 2007 | 1073 | 0.150 |
Why?
|
| Adolescent | 10 | 2019 | 32783 | 0.150 |
Why?
|
| Curriculum | 1 | 2024 | 916 | 0.150 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 526 | 0.150 |
Why?
|
| Disabled Persons | 1 | 2019 | 112 | 0.150 |
Why?
|
| Cotinine | 1 | 2017 | 42 | 0.150 |
Why?
|
| Heart Defects, Congenital | 2 | 2010 | 1789 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2023 | 1822 | 0.140 |
Why?
|
| Young Adult | 6 | 2020 | 22293 | 0.140 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 377 | 0.140 |
Why?
|
| Cluster Analysis | 1 | 2020 | 1075 | 0.140 |
Why?
|
| Research Subjects | 1 | 2017 | 63 | 0.140 |
Why?
|
| Intelligence | 2 | 2008 | 133 | 0.130 |
Why?
|
| Amniotic Fluid | 1 | 2017 | 153 | 0.130 |
Why?
|
| Child | 7 | 2022 | 30596 | 0.120 |
Why?
|
| Mothers | 2 | 2013 | 415 | 0.120 |
Why?
|
| Nicotine | 1 | 2017 | 265 | 0.120 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 147 | 0.120 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 2346 | 0.120 |
Why?
|
| Infertility, Female | 1 | 2016 | 209 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2002 | 1064 | 0.120 |
Why?
|
| Health Behavior | 1 | 2019 | 601 | 0.120 |
Why?
|
| Logistic Models | 3 | 2019 | 3445 | 0.120 |
Why?
|
| Genetic Association Studies | 3 | 2020 | 1098 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 1581 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 1023 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2020 | 1647 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2024 | 1452 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 684 | 0.100 |
Why?
|
| Motivation | 2 | 2007 | 519 | 0.100 |
Why?
|
| Child Rearing | 1 | 2012 | 30 | 0.100 |
Why?
|
| Neurologic Examination | 1 | 2012 | 261 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 2112 | 0.100 |
Why?
|
| Infant | 5 | 2020 | 14045 | 0.100 |
Why?
|
| Personality Inventory | 1 | 2012 | 195 | 0.100 |
Why?
|
| Social Class | 1 | 2013 | 324 | 0.090 |
Why?
|
| Aged | 5 | 2020 | 73545 | 0.090 |
Why?
|
| Intelligence Tests | 2 | 2008 | 88 | 0.090 |
Why?
|
| Executive Function | 1 | 2012 | 146 | 0.090 |
Why?
|
| Demography | 1 | 2012 | 434 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2018 | 1576 | 0.090 |
Why?
|
| Ghana | 1 | 2010 | 16 | 0.090 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2010 | 35 | 0.090 |
Why?
|
| Parents | 1 | 2017 | 1081 | 0.090 |
Why?
|
| Sex Ratio | 1 | 2009 | 14 | 0.080 |
Why?
|
| Sister Chromatid Exchange | 1 | 2009 | 45 | 0.080 |
Why?
|
| Paternal Age | 1 | 2009 | 13 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2011 | 338 | 0.080 |
Why?
|
| Mental Processes | 1 | 2008 | 53 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 4104 | 0.080 |
Why?
|
| Oogenesis | 1 | 2008 | 74 | 0.080 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2008 | 125 | 0.080 |
Why?
|
| Principal Component Analysis | 1 | 2008 | 223 | 0.080 |
Why?
|
| Neonatal Screening | 1 | 2009 | 188 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2009 | 748 | 0.070 |
Why?
|
| Microsatellite Repeats | 1 | 2009 | 627 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2020 | 8709 | 0.070 |
Why?
|
| Information Systems | 1 | 2007 | 53 | 0.070 |
Why?
|
| Attention | 1 | 2008 | 287 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 3845 | 0.070 |
Why?
|
| Prevalence | 2 | 2007 | 3412 | 0.070 |
Why?
|
| Radiography | 1 | 2011 | 1993 | 0.070 |
Why?
|
| DNA Primers | 2 | 2009 | 1492 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 4326 | 0.060 |
Why?
|
| Cognition | 2 | 2009 | 970 | 0.060 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2005 | 36 | 0.060 |
Why?
|
| Mathematical Computing | 1 | 2004 | 23 | 0.060 |
Why?
|
| Genome, Human | 1 | 2013 | 1896 | 0.060 |
Why?
|
| Memory | 1 | 2008 | 444 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2007 | 520 | 0.060 |
Why?
|
| Spermatogenesis | 1 | 2007 | 268 | 0.060 |
Why?
|
| Premenopause | 1 | 2005 | 136 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2007 | 313 | 0.060 |
Why?
|
| Education | 1 | 2024 | 125 | 0.060 |
Why?
|
| United States | 3 | 2007 | 15889 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2011 | 4503 | 0.050 |
Why?
|
| Risk | 2 | 2020 | 1937 | 0.050 |
Why?
|
| Thinking | 1 | 2022 | 36 | 0.050 |
Why?
|
| Prenatal Diagnosis | 1 | 2007 | 609 | 0.050 |
Why?
|
| Point Mutation | 1 | 2005 | 788 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 2571 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 4392 | 0.050 |
Why?
|
| Peer Group | 1 | 2022 | 140 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 7320 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2004 | 485 | 0.050 |
Why?
|
| Educational Measurement | 1 | 2024 | 398 | 0.050 |
Why?
|
| DNA | 1 | 2009 | 3045 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2004 | 825 | 0.050 |
Why?
|
| Comorbidity | 2 | 2022 | 2394 | 0.050 |
Why?
|
| Documentation | 1 | 2022 | 213 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2004 | 1567 | 0.040 |
Why?
|
| Algorithms | 1 | 2011 | 3904 | 0.040 |
Why?
|
| Brain | 2 | 2011 | 4205 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 5102 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2004 | 2317 | 0.040 |
Why?
|
| Dental Care | 1 | 2019 | 14 | 0.040 |
Why?
|
| Haplotypes | 1 | 2002 | 909 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2011 | 6779 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2009 | 2770 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 367 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 3587 | 0.040 |
Why?
|
| Immunization | 1 | 2019 | 393 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 168 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2019 | 216 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2018 | 396 | 0.030 |
Why?
|
| Seizures | 1 | 2022 | 997 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2022 | 840 | 0.030 |
Why?
|
| Fetal Development | 1 | 2017 | 118 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2019 | 354 | 0.030 |
Why?
|
| Health Status | 1 | 2019 | 629 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2018 | 501 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2020 | 9478 | 0.030 |
Why?
|
| Metabolomics | 1 | 2017 | 503 | 0.030 |
Why?
|
| Preconception Care | 1 | 2013 | 20 | 0.030 |
Why?
|
| Vaccination | 1 | 2019 | 1148 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2019 | 765 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 855 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2020 | 5662 | 0.020 |
Why?
|
| Causality | 1 | 2010 | 176 | 0.020 |
Why?
|
| Klinefelter Syndrome | 1 | 2009 | 20 | 0.020 |
Why?
|
| Decision Making | 1 | 2017 | 1253 | 0.020 |
Why?
|
| Animals | 2 | 2022 | 61554 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2009 | 415 | 0.020 |
Why?
|
| Genomics | 1 | 2020 | 2832 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2013 | 551 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 31078 | 0.020 |
Why?
|
| Syndrome | 1 | 2012 | 1409 | 0.020 |
Why?
|
| Smoking | 1 | 2017 | 2555 | 0.020 |
Why?
|
| Follicular Phase | 1 | 2005 | 18 | 0.020 |
Why?
|
| Menarche | 1 | 2005 | 49 | 0.020 |
Why?
|
| Menstruation | 1 | 2005 | 35 | 0.020 |
Why?
|
| Language | 1 | 2005 | 326 | 0.010 |
Why?
|
| Base Sequence | 1 | 2009 | 5417 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 17095 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 3204 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2010 | 2163 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 6655 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 5165 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 5841 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2005 | 2233 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 4966 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 7899 | 0.000 |
Why?
|